COGLIATI DEZZA, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 395
NA - Nord America 309
AS - Asia 136
AF - Africa 10
SA - Sud America 1
Totale 851
Nazione #
US - Stati Uniti d'America 305
IT - Italia 282
SG - Singapore 80
SE - Svezia 40
FI - Finlandia 22
IN - India 21
ID - Indonesia 16
CN - Cina 15
DE - Germania 11
BG - Bulgaria 8
GB - Regno Unito 5
CA - Canada 4
RU - Federazione Russa 4
TG - Togo 4
IE - Irlanda 3
LT - Lituania 3
RO - Romania 3
BE - Belgio 2
BJ - Benin 2
FR - Francia 2
NL - Olanda 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
UA - Ucraina 2
CL - Cile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 851
Città #
Rome 104
Singapore 62
Chandler 47
Fairfield 35
Milan 30
Santa Clara 22
Helsinki 18
New York 16
Jakarta 15
Ashburn 14
Woodbridge 14
Houston 10
Boardman 9
Pesaro 9
Stockholm 9
Cambridge 8
San Paolo di Civitate 8
Sofia 8
Wilmington 7
Princeton 6
Lawrence 5
Naples 5
Dallas 4
Hyderabad 4
Lappeenranta 4
Lomé 4
London 4
Los Angeles 4
Norwalk 4
Reggio Emilia 4
Seattle 4
Andover 3
Bari 3
Bengaluru 3
Boston 3
Delhi 3
Dublin 3
Florence 3
Montesarchio 3
Portland 3
San Diego 3
Toronto 3
Ann Arbor 2
Ardea 2
Ascoli Piceno 2
Belgrade 2
Bremen 2
Brussels 2
Catania 2
Ceppaloni 2
Civitavecchia 2
Cotonou 2
Crevalcore 2
Des Moines 2
Fiuggi 2
Foggia 2
Guangzhou 2
Guidonia Montecelio 2
Hangzhou 2
Latina 2
Lucca 2
Mahé 2
Millbury 2
Montefiascone 2
Moscow 2
Nanjing 2
Pescara 2
Phuket 2
Rodano 2
Romainville 2
San Mateo 2
Tortona 2
Trento 2
Amsterdam 1
Ardesio 1
Beijing 1
Brno 1
Bühl 1
Chieti 1
Cologne 1
Dearborn 1
Edinburgh 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Gazzo 1
Genoa 1
Ischia di Castro 1
Jiaxing 1
Livorno 1
Magliano Sabina 1
Mannheim 1
Melzo 1
Montréal 1
Muizenberg 1
North Bergen 1
Novara 1
Olongapo City 1
Oslo 1
Palermo 1
Totale 619
Nome #
Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside 93
Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia 82
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection 80
Real life experience on the use of anti-SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression among inpatients and outpatients: a monocentric experience 76
Major reduction of NKT cells in patients with severe COVID-19 pneumonia 74
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies. Results from the HM-COV 2.0 study 54
Are Follow-Up Blood Cultures useful in the antimicrobial management of gram negative bacteremia? A reappraisal of their role based on current knowledge 50
Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared 49
Evaluation of immunogenicity to three doses of the SARS-CoV-2 BNT162b2 mRNA vaccine in lung transplant patients 48
Risk factors for carbapenem-resistant Acinetobacter baumannii (crab) bloodstream infections and related mortality in critically ill patients with (crab) colonization 40
Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19 38
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae. Results from a multicentre retrospective study 31
Challenges in the Clinical Management of {SARS}-{CoV}2-Infected Patients with Haematological Malignancies 30
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study 25
null 24
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study 18
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii. A multi-centre clinical experience 18
The long-term Immunogenicity of mRNABNT162b third vaccine dose in solid organ transplant recipients 17
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era. A single center, observational study 17
New antimicrobials and new therapy strategies for endocarditis. Weapons that should be defended 13
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study 12
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study 10
Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study 10
null 7
null 4
Totale 920
Categoria #
all - tutte 4.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 3 3 4 2 2 3 1
2020/202145 1 2 1 0 0 8 0 1 26 4 1 1
2021/2022119 10 27 2 10 10 7 4 4 4 1 29 11
2022/2023223 16 33 21 27 25 18 1 22 17 2 19 22
2023/2024239 19 17 11 15 18 47 6 24 5 39 21 17
2024/2025254 12 45 27 64 56 50 0 0 0 0 0 0
Totale 920